Tandem Diabetes Care (NASDAQ:TNDM) Earns “Equal Weight” Rating from Wells Fargo & Company
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by analysts at Wells Fargo & Company in a research report issued on Monday, Marketbeat reports. They currently have a $22.00 price target on the medical device company’s stock, down from their prior price target of $38.00. Wells Fargo & […]
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by analysts at Wells Fargo & Company in a research report issued on Monday, Marketbeat reports. They currently have a $22.00 price target on the medical device company’s stock, down from their prior price target of $38.00. Wells Fargo & […]
